Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00278473 · ClinicalTrials.gov registry record · NA
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults
A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT00278473: Completed NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00278473 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 88 participants, below the 351-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00278473, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).
Primary Outcome
Adult Attention Deficit Hyperactivity Disorder (ADHD) Investigator Symptom Rating Scale (AISRS) Inattention subscale. Mean change score at 12 weeks as compared to baseline. Each item is scored as follows: 0 (none), 1 (mild), 2 (moderate), 3 (severe); the maximum total score with 27 points being the most severe.
Conditions Studied
Interventions
- BEHAVIORAL Supportive Therapy
- BEHAVIORAL Meta-Cognitive Therapy
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-10 |
| Phase | NA |
What the finished NCT00278473 record still lists
NCT00278473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 351-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 2 interventions - of which Supportive Therapy is the first listed.
NCT00278473 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00278473 about?
NCT00278473 is a clinical study titled "Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults". This study will determine the effectiveness of group cognitive-behavioral therapy as compared to a problem-solving social support group in treating problems of time management, organization, and planning in adults with attention deficit hyperactivity disorder (ADHD).
What is the current status of trial NCT00278473?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2005-05. Estimated completion is 2008-10.
What conditions does trial NCT00278473 study?
This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.
What interventions are being tested in trial NCT00278473?
The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Meta-Cognitive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00278473?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00278473 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Disorder With Hyperactivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00278473's enrollment target sits among peer trials
88 14th of 20 higher than 7 of 20 other Attention Deficit Disorder With Hyperactivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Attention Deficit Disorder With Hyperactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
RECRUITING · NA
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD
COMPLETED · NA
-
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
COMPLETED · NA
-
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
COMPLETED · NA
-
Software Treatment for Actively Reducing Severity of ADHD - Follow Up
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia